文献速递新发突发、热带与寄生虫病

非洲流感疫苗效力、效果与免疫原性的系统综述

The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review.
PubMed 文献 · Lancet Infect Dis · 2018-12-12

该研究遵循PRISMA指南系统检索Embase、MEDLINE、Global Health和Web of Science等数据库,评估非洲人群流感疫苗的效力、效果与免疫原性。共纳入23篇文献,仅3篇为高质量研究,且全部来自6个非洲国家(其中16篇来自南非)。研究提示非洲流感疫苗性能数据存在显著缺口,亟需更广泛人群的高质量研究以指导疫苗政策。

要点

  • 非洲流感疫苗研究仅覆盖6国,南非占16/23,代表性有限。
  • 仅3/23研究为高质量,多数研究统计效能不足。
  • 疟疾、HIV和营养不良等干扰因素研究不足,需进一步探讨。

核心结论

  • 非洲流感疫苗性能数据存在显著缺口,填补这些缺口对指导未来疫苗政策至关重要。

研究设计与样本

  • 遵循PRISMA指南的系统综述(PROSPERO CRD42017058107),检索Embase、MEDLINE、Global Health和Web of Science从建库至2018年5月9日的文献,并检索ClinicalTrials.gov和泛非临床试验注册库及联系专家获取未发表研究。
  • 评估1746篇文章后纳入23篇报告非洲人群流感疫苗免疫原性、效果或效力的研究。

主要发现

  • 23篇纳入研究中仅3篇为高质量,许多研究统计效能不足。
  • 全部23篇研究来自6个非洲国家,其中16篇来自南非。
  • 多数研究聚焦针对实验室确诊流感的效力或效果,对严重结局的数据有限。
  • 疟疾、HIV和营养不良等已知干扰流感免疫接种的因素在本综述中代表性不足。

临床怎么用

  • 临床医生应了解非洲流感疫苗性能数据有限且多来自南非,在其它非洲地区应用时需结合本地证据。
  • 对疟疾、HIV感染或营养不良等可能影响流感免疫接种的人群,应关注其疫苗应答可能不同。

局限性

  • 仅3篇研究为高质量,多数研究统计效能不足。
  • 研究仅来自6个非洲国家,地理代表性有限。
  • 对严重结局的数据有限。
  • 疟疾、HIV和营养不良等干扰因素代表性不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The burden of influenza in Africa is substantial and underappreciated. Although surveillance has increased, the medical community's understanding of seasonal influenza vaccine performance remains limited. We did a systematic review, using PRISMA guidelines (PROSPERO CRD42017058107), on the efficacy, effectiveness, and immunogenicity of influenza vaccines in populations within Africa with the aim of identifying key data gaps to help direct future research. We searched Embase, MEDLINE, Global Health database, and Web of Science for published studies from database inception to May 9, 2018. Unpublished studies were identified by searching ClinicalTrials.gov and the Pan-African Clinical Trial Registry, and by contacting experts within the field. Human studies that reported influenza vaccine immunogenicity, effectiveness, and efficacy were included. 1746 articles were assessed and 23 articles were included. Only three of the 23 studies were of high quality and many studies were underpowered. All 23 studies came from only six African countries (16 from South Africa), highlighting the need for data from a broader range of African populations. The majority of studies focused on effectiveness or efficacy against laboratory supported influenza with limited data for severe outcomes. Several factors known to interfere with influenza immunisation, such as malaria, HIV, and malnutrition were under-represented in this Review and require further study. Substantial gaps exist in our understanding of influenza vaccine performance across all WHO high-risk groups in Africa. Filling these knowledge gaps is vital to guide future influenza vaccine policies.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lindsey BB, Armitage EP, Kampmann B, et al. The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review. Lancet Infect Dis. 2018. PMID: 30553695. doi:10.1016/S1473-3099(18)30490-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。